Seeking Alpha

In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity...

In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity intervention business,including a potential sale of the business unit. If it does pursue that option however, the company adds that it intends to offset any potential earnings dilution related to the transaction.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)